Compare STVN & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STVN | FSK |
|---|---|---|
| Founded | 1949 | 2007 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.2B |
| IPO Year | 2021 | 2008 |
| Metric | STVN | FSK |
|---|---|---|
| Price | $15.43 | $10.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 8 |
| Target Price | ★ $25.67 | $13.94 |
| AVG Volume (30 Days) | 524.4K | ★ 4.8M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | 0.40% | ★ 19.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.26 | N/A |
| Revenue Next Year | $10.02 | N/A |
| P/E Ratio | ★ $27.15 | $259.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.91 | $10.04 |
| 52 Week High | $28.00 | $22.68 |
| Indicator | STVN | FSK |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 26.87 |
| Support Level | $14.03 | $10.28 |
| Resistance Level | $17.14 | $16.05 |
| Average True Range (ATR) | 0.83 | 0.45 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 38.75 | 13.27 |
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.